Canivet J L, Damas P, Lamy M
Department of Anesthesiology and Intensive Care, University Hospital of Liège, Belgium.
Acta Anaesthesiol Belg. 1990;41(1):47-50.
Severe acute hypercalcemia (4.03 mmol/l) developed in a 50 years old woman after head and intraabdominal trauma (and splenectomy). After failure to correct the calcium levels by intravenous saline, furosemide, steroids and calcitonin, two hemodialyses were performed; definitive control of hypercalcemia was obtained by intravenous (3-amino-1-hydroxypropylidene)-1.1-bisphosphonic acid (APD). APD is a new drug analog of pyrophosphate; its main property is to block bone resorption, irrespective of its stimulus. As suspected by clinical and laboratory data and confirmed by arteriographic findings, surgery and pathologic examination, the underlying pathology was a mild primary hyperparathyroidism which was acutely worsened (parathyroid crisis) in the course of the trauma. Definitive treatment consisted of the removal of the adenoma responsible of the hyperparathyroidism.
一名50岁女性在头部和腹部创伤(以及脾切除术后)后出现严重急性高钙血症(4.03 mmol/l)。在通过静脉输注生理盐水、呋塞米、类固醇和降钙素未能纠正钙水平后,进行了两次血液透析;通过静脉注射(3-氨基-1-羟基亚丙基)-1,1-二膦酸(APD)获得了高钙血症的最终控制。APD是一种新的焦磷酸盐类似物;其主要特性是阻断骨吸收,无论其刺激因素如何。正如临床和实验室数据所怀疑并经动脉造影结果、手术及病理检查所证实的那样,潜在病理是轻度原发性甲状旁腺功能亢进,在创伤过程中急性加重(甲状旁腺危象)。确定性治疗包括切除导致甲状旁腺功能亢进的腺瘤。